T细胞耗竭与驻留动态提示肝细胞癌的临床结局
该研究分析了40例肝细胞癌患者(其中10例接受抗PD-1治疗)外周血、肿瘤及癌旁肝组织中耗竭与驻留T细胞的特点,发现肿瘤微环境中严重耗竭CD8+ T细胞富集与较差的无进展生存和总生存相关,而CD103+组织驻留记忆T细胞富集与较好生存相关,基线TRM/TEX比值较高与抗PD-1治疗后疾病控制相关。
要点
- 肿瘤微环境中严重耗竭CD8+ T细胞富集与较差的无进展生存和总生存相关。
- 表达PD-1但额外免疫检查点较少的CD103+组织驻留记忆T细胞与较好生存相关。
- 基线TRM/TEX比值较高与抗PD-1治疗患者的疾病控制相关。
核心结论
- 外周和瘤内TEX-TRM动态可提示肝细胞癌患者结局,并可能用于免疫诊断、患者选择和免疫治疗监测。
研究设计与样本
- 研究纳入40例肝细胞癌患者(其中10例接受抗PD-1治疗),从血液、肿瘤及癌旁肝组织分离淋巴细胞。
- 采用质谱和流式细胞术进行离体和体外表型、功能及抗PD-1反应分析,并用免疫组化和成像质谱细胞术评估组织驻留。
- 对来自癌症基因组图谱的肝细胞癌肿瘤转录组进行计算机基因特征分析。
主要发现
- 肿瘤微环境中存在显著富集的异质性耗竭CD8+ T细胞(TEX)群体。
- 表达多个免疫检查点(除PD-1外)的严重耗竭CD8 T细胞强富集与较差的无进展生存和总生存相关。
- PD-1也表达于部分功能更强、代谢更活跃的CD103+组织驻留记忆T细胞(TRM),这些细胞表达的额外免疫检查点较少,与较好生存相关。
- 在本队列中,TEX富集作为无进展生存的变量独立于BCLC分期、甲胎蛋白水平或年龄。
- 基线TRM/TEX比值较高与抗PD-1治疗患者的疾病控制相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Despite recent translation of immunotherapies into clinical practice, the immunobiology of hepatocellular carcinoma (HCC), in particular the role and clinical relevance of exhausted and liver-resident T cells remain unclear. We therefore dissected the landscape of exhausted and resident T cell responses in the peripheral blood and tumor microenvironment of patients with HCC. METHODS: Lymphocytes were isolated from the blood, tumor and tumor-surrounding liver tissue of patients with HCC (n = 40, n = 10 treated with anti-PD-1 therapy). Phenotype, function and response to anti-PD-1 were analyzed by mass and flow cytometry ex vivo and in vitro, tissue residence was further assessed by immunohistochemistry and imaging mass cytometry. Gene signatures were analyzed in silico. RESULTS: We identified significant enrichment of heterogeneous populations of exhausted CD8+ T cells (TEX) in the tumor microenvironment. Strong enrichment of severely exhausted CD8 T cells expressing multiple immune checkpoints in addition to PD-1 was linked to poor progression-free and overall survival. In contrast, PD-1 was also expressed on a subset of more functional and metabolically active CD103+ tissue-resident memory T cells (TRM) that expressed few additional immune checkpoints and were associated with better survival. TEX enrichment was independent of BCLC stage, alpha-fetoprotein levels or age as a variable for progression-free survival in our cohort. These findings were in line with in silico gene signature analysis of HCC tumor transcriptomes from The Cancer Genome Atlas. A higher baseline TRM/TEX ratio was associated with disease control in anti-PD-1-treated patients. CONCLUSION: Our data provide information on the role of peripheral and intratumoral TEX-TRM dynamics in determining outcomes in patients with HCC. The dynamics between exhausted and liver-resident T cells have implications for immune-based diagnostics, rational patient selection and monitoring during HCC immunotherapies. LAY SUMMARY: The role of the immune response in hepatocellular carcinoma (HCC) remains unclear. T cells can mediate protection against tumor cells but are frequently dysfunctional and exhausted in cancer. We found that patients with a predominance of exhausted CD8+ T cells (TEX) had poor survival compared to patients with a predominance of tissue-resident memory T cells (TRM). This correlated with the molecular profile, metabolic and functional status of these cell populations. The enrichment of TEX was independently associated with prognosis in addition to disease stage, age and tumor markers. A high TRM proportion was also associated with better outcomes following checkpoint therapy. Thus, these T-cell populations are novel biomarkers with relevance in HCC.
引用
- Barsch M, Salié H, Schlaak AE, et al. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma. J Hepatol. 2022. PMID: 35367533. doi:10.1016/j.jhep.2022.02.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。